Literature DB >> 2187485

Purification, assay and kinetic features of HIV-1 proteinase.

A Billich1, F Hammerschmid, G Winkler.   

Abstract

1) The aspartic proteinase of the human immunodeficiency virus type 1 (HIV-1) was purified from cultures of recombinant E. coli. The enzyme preparation is homogeneous as judged by SDS-polyacrylamide gel electrophoresis and isoelectric focusing. 2) A rapid assay procedure for the proteinase was established which makes use of the cleavage of a radiolabeled decapeptide and the separation of substrate and labeled product by ion-exchange resin. 3) Activity of the enzyme is optimal at an ionic strength of 2.5-3.5M; also, the inhibitor pepstatin is a more potent inhibitor at higher ionic strength. This can be attributed to a tighter binding of both substrate and inhibitor in high-salt buffer. 4) The Km value of the decapeptide substrate is independent of the pH in the range of 3.5-7.5, while kcat shows a bell-shaped curve with a maximum at pH 5.2. The shape of the curve can be attributed to pKa values of 4.2 and 6.2 of groups on the enzyme. Pepstatin inhibition is optimal below pH 5.5, but becomes weak above pH 6.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2187485

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  11 in total

1.  A genetic system for studying the activity of a proteolytic enzyme.

Authors:  B Dasmahapatra; B DiDomenico; S Dwyer; J Ma; I Sadowski; J Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

2.  beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.

Authors:  E Z Baum; G A Bebernitz; Y Gluzman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  A yeast-based growth assay for the analysis of site-specific proteases.

Authors:  Fabian Köhler
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

4.  Characterization of the protease of a fish retrovirus, walleye dermal sarcoma virus.

Authors:  Sharon K Fodor; Volker M Vogt
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

5.  Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.

Authors:  J M Louis; N T Nashed; K D Parris; A R Kimmel; D M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

6.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.

Authors:  A Steinkasserer; R Harrison; A Billich; F Hammerschmid; G Werner; B Wolff; P Peichl; G Palfi; W Schnitzel; E Mlynar
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions.

Authors:  A Billich; F Hammerschmid; P Peichl; R Wenger; G Zenke; V Quesniaux; B Rosenwirth
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

8.  SDZ PRI 053, an orally bioavailable human immunodeficiency virus type 1 proteinase inhibitor containing the 2-aminobenzylstatine moiety.

Authors:  A Billich; G Fricker; I Müller; P Donatsch; P Ettmayer; H Gstach; P Lehr; P Peichl; D Scholz; B Rosenwirth
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

9.  Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.

Authors:  B Rosenwirth; A Billich; R Datema; P Donatsch; F Hammerschmid; R Harrison; P Hiestand; H Jaksche; P Mayer; P Peichl
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

10.  HIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partner.

Authors:  Gilles Mirambeau; Sébastien Lyonnais; Dominique Coulaud; Laurence Hameau; Sophie Lafosse; Josette Jeusset; Isabelle Borde; Michèle Reboud-Ravaux; Tobias Restle; Robert J Gorelick; Eric Le Cam
Journal:  PLoS One       Date:  2007-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.